Company Profiles

driven by the PitchBook Platform

Cerevast Therapeutics

Description

Developer of tools for the treatment of ischemic stroke and other vascular disorders. The company develops treatment for acute ischemic stroke using a combination therapy, known as sonothrombolyis.

2009

Founded

PRIVATE

Status

11-50

Employees

2ndary - Private

Latest Deal Type

$32.5M

Total Amount Raised

4

Investors

Description

Developer of tools for the treatment of ischemic stroke and other vascular disorders. The company develops treatment for acute ischemic stroke using a combination therapy, known as sonothrombolyis.

Website:

www.cerevast.com

Formerly Known As

WA32609

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Surgical Devices

Primary Office

11601 Willows Road Northeast Suite 100 Redmond, WA 98052United States +1 (425) 748-7529
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Cerevast Therapeutics's full profile, request a free trial.

    Cerevast Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Cerevast Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Cerevast Therapeutics Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Genstar CapitalPE/BuyoutMinority000 0000000 0000
    Icos CapitalVenture CapitalMinority000 0000000 0000
    UT Horizon FundVenture CapitalMinority000 0000000 0000
    VerathonCorporationMinority000 0000000 0000
    Genstar Capital PE/Buyout
    Icos Capital Venture Capital
    UT Horizon Fund Venture Capital
    Verathon Corporation

    Cerevast Therapeutics Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Bradford ZakesChief Executive Officer
    John AllemanChief Operating Officer
    Patrick BobbittVice President of Clinical Affairs
    Anthony AllemanVice President of Operations
    Andrew LeoVice President, Regulatory & Quality Affairs
    Bradford Zakes Chief Executive Officer
    John Alleman Chief Operating Officer
    Patrick Bobbitt Vice President of Clinical Affairs
    Anthony Alleman Vice President of Operations
    Andrew Leo Vice President, Regulatory & Quality Affairs

    Cerevast Therapeutics Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Fredric Moll MDSelfDirector000 0000
    Gerald McMorrowVerathonFounder, Chairman & Chief Executive Officer000 0000
    Paul ClarkGenstar CapitalOperating Partner000 0000
    Yuquan WangSelfBoard Member000 0000
    Fredric Moll MD Director Self
    Gerald McMorrow Founder, Chairman & Chief Executive Officer Verathon
    Paul Clark Operating Partner Genstar Capital
    Yuquan Wang Board Member Self
    Request full access to PitchBook